0001209191-18-037347.txt : 20180612
0001209191-18-037347.hdr.sgml : 20180612
20180612202637
ACCESSION NUMBER: 0001209191-18-037347
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180611
FILED AS OF DATE: 20180612
DATE AS OF CHANGE: 20180612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mento Steven J
CENTRAL INDEX KEY: 0001324466
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 18895676
MAIL ADDRESS:
STREET 1: C/O SANGAMO BIOSCIENCES, INC.
STREET 2: 501 CANAL BLVD SUITE A-100
CITY: RICHMOND
STATE: CA
ZIP: 94804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
FORMER COMPANY:
FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC
DATE OF NAME CHANGE: 20000208
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-11
0
0001001233
SANGAMO THERAPEUTICS, INC
SGMO
0001324466
Mento Steven J
C/O SANGAMO THERAPEUTICS, INC.
POINT RICHMOND TECH CTR, 501 CANAL BLVD.
RICHMOND
CA
94804
1
0
0
0
Common Stock
2018-06-11
4
A
0
2500
0.00
A
14332
D
Common Stock
32214
I
By Trust
Stock Option (Right to Buy)
15.65
2018-06-11
4
A
0
15000
0.00
A
2028-06-10
Common Stock
15000
15000
D
Represents shares of common stock issuable upon settlement of restricted stock units ("RSUs"). The RSUs will fully vest on the earlier of (x) June 11, 2019 (the first anniversary of the date of grant) or (y) the day prior to the 2019 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
These shares are held by Steven J. Mento and Linda A. Mento, Trustees of the Mento Family Trust dated December 29, 1994.
Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's service on the Board of the Directors of the Issuer. The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Board service over the 12-month period measured from the grant date.
/s/ Denise Winn, Attorney-in-Fact
2018-06-12